CoChat

AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS

Macintyre, Iain · 1989 · The Lancet

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Amylinamide is a potent osteoclast-inhibiting peptide that is co-secreted with insulin from the beta cell. It induces profound hypocalcaemia in rats and rabbits and abolishes bone resorption by isolated osteoclasts in vitro. The non-amidated human peptide forms an insoluble fibrillar amyloid deposit that may interfere with beta-cell function and precipitate type II diabetes.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(89)91028-3

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Cited by

See all 56

Metadata

Authors
Macintyre, I.
Corresponding author
Macintyre, Iain
Venue
The Lancet
Publisher
Elsevier BV
Published
1989-10
Volume
334
Issue
8670
Pages
1026-1027
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2040428897
Cited by
56
References
16
Citations by year
2022: 1 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 1 · 2012: 2
FWCI
0.89
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
amylin, osteoclast inhibition, bone resorption, bone preservation, pancreatic beta cells, hypocalcemia, amyloid deposition, type 2 diabetes
MeSH terms
Insulin Secretion, Amyloid, Animals, Bone Resorption, Calcitriol, Calcium, Diabetes Mellitus, Type 2, Homeostasis, Humans, Insulin, Islets of Langerhans, Rabbits, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS. https://app.cochat.ai/papers/10.1016/s0140-6736(89)91028-3
The paper
Macintyre, I. (1989). AMYLINAMIDE, BONE CONSERVATION, AND PANCREATIC β CELLS. The Lancet. https://doi.org/10.1016/s0140-6736(89)91028-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.